Loading
The US defense department's kidney cancer research fund, created by Congress in 2017 with 10 million dollars. It funds work on the biology of kidney cancer, new treatments, patient care and training new researchers.
In FY17 Congress directed $10 million to kidney cancer research in the Department of Defense appropriation, establishing the Kidney Cancer Research Program. Its stated vision is to eliminate kidney cancer through collaboration and discovery. The page cites tobacco smoking and environmental and occupational exposures as known risk factors and notes service members' exposure to chlorinated solvents, petrochemicals and heavy metals. Its strategic goals are to increase understanding of the biology of kidney cancer, develop new therapeutic strategies, improve patient care, and grow the field and collaboration.
The page lists congressional appropriations of $285 million for FY17 to FY24 and $15 million for FY26, and 347 awards in FY17 to FY24.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/